Home › Leukemia › Indiana › Indianapolis
Leukemia clinical trials in Indianapolis, IN
3 studies for Leukemia are looking for participants at sites in and around Indianapolis (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
RecruitingObservational study
- Riley Hospital for Children, Indianapolis
- Saint Vincent Hospital and Health Care Center, Indianapolis
First-in-human Study of a New Treatment (4A10) for Patients With Relapsed or Hard-to-treat Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma, Focused on Safety and How the Drug Behaves in the Body and Early Signs of Effect.
RecruitingPhase 1
- Riley Children's Hosptial, Indianapolis
CD4CAR for CD4+ Leukemia and Lymphoma
RecruitingPhase 1
- Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis
- Riley Hospital for Children, Indianapolis
About Leukemia
Leukemia is cancer of the white blood cells. There are two types of Leukemias, acute and chronic. Learn about the differences and treatments available.
More about Leukemia on MedlinePlus
Leukemia trials in other cities
- Houston, TX31 studies
- Boston, MA27 studies
- New York City, NY21 studies
- Chicago, IL19 studies
- Los Angeles, CA17 studies
- Durham, NC14 studies
- Baldwin Park, CA14 studies
- Nashville, TN13 studies
- Columbus, OH13 studies
- Philadelphia, PA13 studies
- Atlanta, GA12 studies
- Milwaukee, WI12 studies
Other studies in Indianapolis
- Non-Small Cell Lung Cancer32 studies
- Cancer (all types)24 studies
- Heart Failure24 studies
- Obesity22 studies
- Breast Cancer19 studies
- Ovarian Cancer18 studies
- Metastatic Cancer17 studies
- Colorectal Cancer17 studies
- Cardiovascular Disease16 studies
- Lung Cancer16 studies
- Type 1 Diabetes14 studies
- Overweight14 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.